A series of informative webinars covering the drug discovery process, from the experts at Medicines Discovery Catapult (MDC) and our CRO network partners.

2pm BST
3rd - 17th June 2020

Book your place

© Medicines Discovery Catapult 2020. All rights reserved. Read our Privacy Policy

Target Validation and Efficacy
2pm BST, Wednesday 3rd June 2020

  • Strategies for target and pathway engagement in cellular assays - Matt Burnham, MDC
  • Go native… Characterising therapeutic effect in primary cellular models - Amanda Woodrooffe, Precision for Medicine
  • Use of pre-clinical models to deliver proof of concept efficacy - Lorraine Mooney, Sygnature Discovery

    Is my Compound Safe?
    2pm BST, Wednesday 10th June 2020

    • Making safety part of drug design - Richard Knight, Apconix
    • How to get your molecule into humans: A practical guide for the present and a look to the future - Pauline Garner, Sequani
    • Challenges and opportunities of complex cell models in toxicity testing - Malcolm Haddrick, MDC

Developing a Biomarker Strategy
2pm BST, Wednesday 17th June 2020

  • Designing a biomarker strategy - Gayle Marshall, MDC
  • The challenges of accessing clinical samples - Helen Hind, MDC
  • Biomarker identification: Assessing immune function - Russell Garland, Charles River Laboratories

More details